KT Corporation
The company will use the investment to expand its technology's current abilities, add capabilities to detect additional health conditions and drive global growth.
Sonde is its second global digital health investment to date.
The telemedicine platform will start by offering diabetes care support.
They plan to infuse AI, big data, and cloud technologies with digital therapeutics.
KT will also open its digital healthcare platform for NeuroSigma's advanced monitoring and AI analysis services.